Trial Profile
GnRH antagonists in the management of hemorrhagic corpus luteum. Clinical and ultrasound study of luteolysis mediated by cetrorelix. [Antagonistas de GnRH en el manejo del cuerpo luteo hemorragico. Estudio clinico y ecografico de la luteolisis mediada por el cetrorelix.]
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2013
Price :
$35
*
At a glance
- Drugs Cetrorelix (Primary)
- Indications Ovarian cyst; Ovulation disorders
- Focus Therapeutic Use
- 07 Jul 2011 New trial record